WEF Welcomes ACG Shirwal as First Pharma Packaging Site in Global Lighthouse Network

Why It Matters

The accolade validates intelligence‑led manufacturing as a competitive edge for pharma supply chains, accelerating cost‑efficiency, quality and sustainability across the industry.

Key Takeaways

• First pharma packaging site in WEF Global Lighthouse Network.
• Digital tools cut defects 71% and lead times 40%.
• Energy use dropped 31%, on‑time delivery up 34%.
• AI, IoT, digital twins drive smart packaging at Shirwal.
• SuperPod™ reduces blister size 39%, triples production per shot.

Pulse Analysis

The World Economic Forum’s Global Lighthouse Network has become a benchmark for factories that combine productivity, sustainability and digital sophistication. ACG’s Shirwal plant joins this elite group, marking a watershed moment for pharmaceutical packaging. By embedding generative AI, machine learning, deep learning, industrial IoT and digital twins, the site achieves unprecedented visibility across the production line, enabling rapid response to process variations and fostering a culture of continuous improvement.

Operational data from Shirwal shows dramatic gains: defect rates fell 71%, lead times shrank 40%, on‑time‑in‑full deliveries rose 34%, and energy consumption dropped 31%. These metrics translate into lower costs for drug manufacturers and more reliable delivery of medicines worldwide. The digital backbone not only boosts efficiency but also supports sustainability goals, aligning with global pressure to reduce carbon footprints and waste in the pharma sector.

Beyond the lighthouse designation, ACG is expanding its innovation pipeline with the SuperPod™ cold‑form blister technology. The new system cuts cavity size by 39% and triples the number of blisters per shot, delivering material savings and higher throughput. Such advances illustrate how intelligence‑led packaging can reshape product design, logistics and environmental impact, positioning ACG as a catalyst for the next generation of resilient, eco‑friendly pharmaceutical supply chains.